Memantine Hydrochloride + Donepezil Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 28 mg+ 10 mg , 14 mg+ 10 mg
Reference Brands: Namzaric (USA)
Category:
Neurology
Memantine Hydrochloride + Donepezil Hydrochloride is available in Capsules
and strengths such as 28 mg+ 10 mg , 14 mg+ 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Memantine Hydrochloride + Donepezil Hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Memantine Hydrochloride + Donepezil Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Namzaric is a combination medicine that contains donepezil and memantine, two active ingredients that work together to support brain function in patients with Alzheimer’s disease. Donepezil improves the function of nerve cells in the brain by preventing the breakdown of acetylcholine, a chemical that plays a key role in memory, thinking, and reasoning. In individuals with dementia, levels of acetylcholine are typically reduced, and donepezil helps increase its availability to support cognitive processes.
Memantine works through a different mechanism by reducing the effects of certain chemicals in the brain that may contribute to the symptoms of Alzheimer’s disease. By regulating abnormal brain activity, memantine helps protect nerve cells and supports cognitive stability. The combination of these two agents provides a complementary approach to managing symptoms associated with Alzheimer’s disease.
Namzaric is used for the treatment of moderate to severe dementia of the Alzheimer’s type. It helps improve cognitive function, supports daily activities, and may slow the progression of symptoms when used as prescribed under medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing